日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A phase II clinical trial on the efficacy and safety of carboplatin plus nab-paclitaxel in chemotherapy-naive advanced or recurrent thymic epithelial tumors: protocol of Nab-TET

一项评估卡铂联合白蛋白紫杉醇治疗初治晚期或复发性胸腺上皮肿瘤疗效和安全性的II期临床试验：Nab-TET方案

期刊:Journal of Thoracic Disease
影响因子:1.9
doi:10.21037/jtd-2025-1110
Hayashi, Fumiko; Matsuo, Midori; Takemoto, Shinnosuke; Ogata, Ryosuke; Umeyama, Yasuhiro; Nakatomi, Katsumi; Ikeda, Takaya; Sugasaki, Nanae; Doi, Seiji; Kitazaki, Takeshi; Akagi, Kazumasa; Tomono, Hiromi; Honda, Noritaka; Dotsu, Yosuke; Taniguchi, Hirokazu; Gyotoku, Hiroshi; Fukuda, Minoru; Soda, Hiroshi; Mukae, Hiroshi
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Phase II study of ramucirumab and docetaxel for previously platinum-treated patients with non-small cell lung cancer and malignant pleural effusion (PLEURAM study)

雷莫芦单抗和多西他赛治疗既往接受过铂类药物治疗的非小细胞肺癌合并恶性胸腔积液患者的 II 期研究（PLEURAM 研究）

期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-24-508
Takemoto, Shinnosuke; Fukuda, Minoru; Ogata, Ryosuke; Senju, Hiroaki; Sugasaki, Nanae; Nakatomi, Katsumi; Tomono, Hiromi; Suyama, Takayuki; Sasaki, Eisuke; Matsuo, Midori; Akagi, Kazumasa; Hayashi, Fumiko; Dotsu, Yosuke; Ono, Sawana; Honda, Noritaka; Taniguchi, Hirokazu; Gyotoku, Hiroshi; Ikeda, Takaya; Nagashima, Seiji; Soda, Hiroshi; Kinoshita, Akitoshi; Mukae, Hiroshi
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Pulmonary Nocardiosis Caused by Nocardia sputorum Identified via 16S rRNA Gene Sequencing: A Case Report

通过16S rRNA基因测序鉴定出由痰诺卡氏菌引起的肺诺卡氏菌病：病例报告

期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.66137
Irifune, Satoshi; Ide, Shotaro; Koga, Satoru; Mine, Keisuke; Sugasaki, Nanae; Kosai, Kosuke; Fukuda, Minoru; Yanagihara, Katsunori; Mukae, Hiroshi
发表日期：2024
文献求助 收藏

Surgically resected lung adenocarcinoma: do heterogeneous GGNs and part-solid nodules on thin-section CT show different prognosis?

手术切除的肺腺癌：薄层CT上的异质性磨玻璃结节和部分实性结节是否预后不同？

期刊:Japanese Journal of Radiology
影响因子:4.1
doi:10.1007/s11604-022-01345-3
Koike, Hirofumi; Ashizawa, Kazuto; Tsutsui, Shin; Fukuda, Minoru; Okano, Shinji; Matsumoto, Keitaro; Nagayasu, Takeshi; Honda, Sumihisa; Uetani, Masataka
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

A Phase 2 Single-Arm Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis NSCLC: Results for the First-Line Cohort of the OCEAN Study (LOGIK 1603/WJOG 9116L)

奥希替尼治疗未接受过放疗的中枢神经系统转移性非小细胞肺癌的 II 期单臂研究：OCEAN 研究一线队列的结果 (LOGIK 1603/WJOG 9116L)

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2023.100587
Wakuda, Kazushige; Yamaguchi, Hiroyuki; Kenmotsu, Hirotsugu; Fukuda, Minoru; Ito, Kentaro; Tsuchiya-Kawano, Yuko; Tanaka, Kentaro; Harada, Taishi; Nakatani, Yuki; Miura, Satoru; Yokoyama, Toshihide; Nakamura, Tomomi; Izumi, Miiru; Nakamura, Atsushi; Ikeda, Satoshi; Takayama, Koichi; Yoshimura, Kenichi; Nakagawa, Kazuhiko; Yamamoto, Nobuyuki; Sugio, Kenji
肺癌
肿瘤
肿瘤免疫
神经科学
细胞生物学
发表日期：2023
文献求助 收藏

Phase II study of IRInotecan treatment after COmbined chemo-immunotherapy for extensive-stage small cell lung cancer: Protocol of IRICO study

伊立替康联合化疗-免疫疗法治疗广泛期小细胞肺癌的II期研究：IRICO研究方案

期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.15097
Tomono, Hiromi; Taniguchi, Hirokazu; Fukuda, Minoru; Ikeda, Takaya; Nagashima, Seiji; Akagi, Kazumasa; Ono, Sawana; Umeyama, Yasuhiro; Shimada, Midori; Gyotoku, Hiroshi; Takemoto, Shinnosuke; Hisamatsu, Yasushi; Morinaga, Ryotaro; Tagawa, Ryuta; Ogata, Ryosuke; Dotsu, Yosuke; Senju, Hiroaki; Soda, Hiroshi; Nakatomi, Katsumi; Hayashi, Fumiko; Sugasaki, Nanae; Kinoshita, Akitoshi; Mukae, Hiroshi
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2023
文献求助 收藏

A Phase II Trial on Osimertinib as a First-Line Treatment for EGFR Mutation-Positive Advanced NSCLC in Elderly Patients: The SPIRAL-0 Study

奥希替尼作为EGFR突变阳性晚期非小细胞肺癌老年患者一线治疗的II期临床试验：SPIRAL-0研究

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyac193
Chihara, Yusuke; Takeda, Takayuki; Goto, Yasuhiro; Nakamura, Yoichi; Tsuchiya-Kawano, Yuko; Nakao, Akira; Onoi, Keisuke; Hibino, Makoto; Fukuda, Minoru; Honda, Ryoichi; Yamada, Takahiro; Taniguchi, Ryusuke; Sakamoto, Sinjiro; Date, Koji; Nagashima, Seiji; Tanzawa, Shigeru; Minato, Koichi; Nakatani, Koichi; Izumi, Miiru; Shimose, Takayuki; Kishimoto, Junji; Uchino, Junji; Takayama, Koichi
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2022
文献求助 收藏

Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-disease small cell lung cancer: protocol of ACIST study

阿姆鲁比星联合顺铂和同步加速超分割胸部放疗治疗局限期小细胞肺癌的I期研究：ACIST研究方案

期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.14555
Akagi, Kazumasa; Taniguchi, Hirokazu; Fukuda, Minoru; Yamazaki, Takuya; Ono, Sawana; Tomono, Hiromi; Suyama, Takayuki; Shimada, Midori; Gyotoku, Hiroshi; Takemoto, Shinnosuke; Yamaguchi, Hiroyuki; Dotsu, Yosuke; Senju, Hiroaki; Soda, Hiroshi; Mizowaki, Takashi; Monzen, Yoshio; Ikeda, Takaya; Nagashima, Seiji; Tasaki, Yutaro; Nakamura, Daisuke; Komiya, Kazutoshi; Nakatomi, Katsumi; Sasaki, Eisuke; Hirakawa, Koichi; Mukae, Hiroshi
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Phase II study of S-1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Results of the LOGIK1605/JART-1501 study

S-1联合顺铂和同步放疗治疗局部晚期胸腺癌的II期研究：LOGIK1605/JART-1501研究结果

期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.14586
Fukuda, Minoru; Yamaguchi, Masafumi; Yamazaki, Takuya; Funaki, Soichiro; Mukae, Hiroshi; Fukuoka, Junya; Nabeshima, Kazuki; Tateyama, Hisashi; Ashizawa, Kazuto; Tomiyama, Noriyuki; Hara, Masaki; Seto, Takashi; Okumura, Meinoshin; Sugio, Kenji
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Proportion of biopsy specimens containing a tumor when compared to all biopsy specimens by transbronchial biopsy

经支气管活检术中，含有肿瘤的活检标本占所有活检标本的比例

期刊:Lung Cancer Management
影响因子:0.7
doi:10.2217/lmt-2022-0001
Takemoto, Shinnosuke; Ozasa, Mutsumi; Mizuta, Remi; Tagawa, Ryuta; Ono, Sawana; Honda, Noritaka; Suyama, Takayuki; Umeyama, Yasuhiro; Dotsu, Yosuke; Gyotoku, Hiroshi; Yamaguchi, Hiroyuki; Yamamoto, Kazuko; Sakamoto, Noriho; Obase, Yasushi; Fukuda, Minoru; Mukae, Hiroshi
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏